This study documents that anemia occurs relatively frequently in COPD patients and is related to the presence of inflammation. Anemia is an understudied issue in COPD but may be of great ...

People in rural areas are at greater risk of developing chronic obstructive pulmonary disease (COPD) due to a variety of factors. We explain why.

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

The C-reactive protein (CRP) is easily checked in blood, and is the most studied inflammatory biomarker in COPD. This acute-phase reactant is secreted by the liver in the setting of infection ...

Steroids are among the medications commonly prescribed to treat COPD. They help reduce the inflammation in your lungs caused by flare-ups. Steroids come in oral and inhaled forms. There are also ...

Columnist Caroline Gainer discusses a study whose findings suggested that respiratory muscle strength training could help ...

The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...

Biologic drugs are designed to target specific parts of the immune system that contribute to chronic inflammatory diseases like COPD. According to Sanofi, the maker of Dupixent, it is the first ...

Cigarette smoking is known to impair the immune system’s response to infections and promote inflammation in the lungs that can lead to or exacerbate COPD, the third leading cause of death worldwide.

New Study Shows Promising Results for COPD Treatment Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave ...

Cigarette smoking is known to impair the immune system's response to infections and promote inflammation in the lungs that can lead to or exacerbate COPD, the third leading cause of death worldwide.

steroid-free compound in the treatment of Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis (IPF), and other deadly lung diseases characterized by pulmonary inflammation.